RxDoctor Payments Data

Xin Liu, DO

Orthopaedic Surgery · Las Vegas, NVNPI 1831205269

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (50.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Goode Surgical Inc at 55.0% of the total. Reporting peaked in 2022 at $2,463 and has fallen 92.7% since, to $180 in 2025.

$6,146in general payments, 2019–2025

Across 72 payments — averaging $85.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Goode Surgical Inc$3K
  • Stryker$2K
  • Smith+Nephew$328
  • Johnson & Johnson$294
  • Amgen$138
  • Abbott$83
  • plus $122 from 3 others

What the payments were for

  • Travel & lodging$1,35222%
  • Food & beverage$1,71728%
  • Education$3,07750%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Goode Surgical Inc15$3,383
Stryker19$1,797
Smith+Nephew4$328
Johnson & Johnson10$294
Amgen20$138
Abbott1$83
Shoulder Innovations, Inc.1$71
ERMI LLC1$34
Avanos Medical1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,146 in reported general payments places this provider in the 55th percentile of 135 orthopaedic surgery providers in Nevada.

See all orthopaedic surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$177,222
Medicare patients
336
Services billed
16,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen12$83

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →